Literature DB >> 7553787

Increased capacity for store regulated calcium influx in U937 cells differentiated by treatment with dibutyryl cAMP.

W Davis1, E L Halliwell, S O Sage, J M Allen.   

Abstract

We have investigated the mechanisms underlying calcium signalling evoked by cross-linking of the high affinity IgG receptor (Fc gamma RI) in populations of the human monocyte-like cell line, U937, following activation of the cells by cytokine treatment, or differentiation to a more macrophage-like state by treatment with dibutyryl cAMP (Bt2cAMP). We have shown previously that a larger and more prolonged entry of external calcium occurs in Bt2cAMP-differentiated cells, although there is a smaller initial release from internal stores in these cells than in those activated by IFN-gamma treatment. In this paper we demonstrate, by use of the endomembrane Ca(2+)-ATPase inhibitor, thapsigargin, that this effect is explained (at least in part) by an enhanced capacity for store regulated entry of calcium in Bt2cAMP-differentiated cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7553787     DOI: 10.1016/0143-4160(95)90108-6

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  3 in total

Review 1.  Receptor-activated Ca2+ inflow in animal cells: a variety of pathways tailored to meet different intracellular Ca2+ signalling requirements.

Authors:  G J Barritt
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

2.  Differentiation of the human monocytic cell line U937 results in an upregulation of the calcium release-activated current, ICRAC.

Authors:  R A Floto; M P Mahaut-Smith; J M Allen; B Somasundaram
Journal:  J Physiol       Date:  1996-09-01       Impact factor: 5.182

3.  Differentiation-dependent switch in protein kinase C isoenzyme activation by FcgammaRI, the human high-affinity receptor for immunoglobulin G.

Authors:  A J Melendez; M M Harnett; J M Allen
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.